The company continues to build validation data and believes its lower cost proposition can help it gain leverage in the European market where molecular tests are not reimbursed.

It’s good news in the fight against colorectal cancer: A new test can detect the disease with a simple blood draw. But don’t ...

The Food and Drug Administration has granted authorization of a COVID-19 and flu test that can be used without a prescription ...

A team of cardiologists shared tips and tricks for clinicians to address the pitfalls they may encounter when conducting ...

POC HBV testing was associated with faster turnaround time for results and higher rates of treatment initiation when compared with standard laboratory-based assays.

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia ...

But which one? Now, at-home rapid tests can simultaneously determine whether someone has COVID-19 or the flu. Thanks in part to the National Institutes of Health’s Rapid Acceleration of Diagnostics, ...

In a recent article published in the journal Nature Communications, researchers have developed a novel plasmonic biosensor as ...

An article recently published in the journal Scientific Reports introduced a novel method for assessing the severity of ...

Exact Sciences expects to launch the updated test, which has higher specificity than its predecessor, with Medicare coverage and guideline inclusion in 2025.

Circulating tumor DNA is a promising tool for the detection and surveillance of HPV-positive oropharyngeal squamous cell ...

In a significant advancement for point-of-care medical diagnostics, a team of researchers from UCLA has introduced a deep ...